N-(2-Hydroxyethyl)-L-valyl-L-leucine in rat urine as a hydrolytic cleavage product of ethylene oxide adduct with globin
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13401-4/2012
Internal Grant Agency of the Czech Ministry of Health - International
IN 75010330
Ministerstvo ZdravotnictvíCeskéRepubliky (CZ) - International
CZ.1.06/3.2.01/11.08435
European Regional Development Fund - International
PubMed
30666356
DOI
10.1007/s00204-019-02388-8
PII: 10.1007/s00204-019-02388-8
Knihovny.cz E-zdroje
- Klíčová slova
- Biomonitoring, Dipeptidic urinary adducts, Ethylene oxide, Globin adducts, Hydrolytic cleavage,
- MeSH
- biologické markery moč MeSH
- dipeptidy metabolismus moč MeSH
- erytrocyty MeSH
- ethylenoxid toxicita MeSH
- globiny metabolismus MeSH
- hydrolýza MeSH
- krysa rodu Rattus MeSH
- leucin MeSH
- monitorování životního prostředí MeSH
- nebezpečné látky toxicita MeSH
- valin chemie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- biologické markery MeSH
- dipeptidy MeSH
- ethylenoxid MeSH
- globiny MeSH
- leucin MeSH
- N-(2-hydroxyethyl)-L-valyl-L-leucine MeSH Prohlížeč
- nebezpečné látky MeSH
- valin MeSH
Ethylene oxide (EO), a genotoxic industrial chemical and sterilant, forms covalent adducts with DNA and also with nucleophilic amino acids in proteins. The adduct with N-terminal valine in globin [N-(2-hydroxyethyl)valine (HEV)] has been used in biomonitoring of cumulative exposures to EO. Here we studied in rats the fate of EO-adducted N-termini of globin after life termination of the erythrocytes. Rat erythrocytes were incubated with EO to produce the HEV levels in globin at 0.4-13.2 µmol/g as determined after acidic hydrolysis. Alternative hydrolysis of the isolated globin with enzyme pronase afforded N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) and N-(2-hydroxyethyl)-L-valyl-L-histidine (HEVH), the EO-adducted N-terminal dipeptides of rat globin α- and β-chains, respectively. The ratio of HEVL/HEVH (1:3) reflected higher reactivity of EO with the β-chain. The EO-modified erythrocytes were then given intravenously to the recipient rats. HEVL and HEVH were found to be the ultimate cleavage products excreted in the rat urine. Finally, rats were dosed intraperitoneally with EO, 50 mg/kg. Herein, the initial level of globin-bound HEVL (11.7 ± 1.3 nmol/g) decreased almost linearly over 60 days corresponding to the life span of rat erythrocytes. Daily urinary excretion of HEVL was almost constant for 30-40 days, decreasing faster in the subsequent phase of elimination. Recoveries of the total urinary HEVL from its globin-bound form were 84 ± 6% and 101 ± 17% after administrations of EO and the EO-modified erythrocytes, respectively. In conclusion, urinary HEVL appears to be a promising novel non-invasive biomarker of human exposures to EO.
Citace poskytuje Crossref.org